Schedule 13G ownership disclosure

CYMABAY THERAPEUTICS INC

Security class unavailable · CUSIP: 23257D103

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,691,325
Percent of class
5.3700%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-20-016437
Form type
SC 13G
Filer
CymaBay Therapeutics, Inc.
CIK
CIK 1042074
Filed
Feb 11, 2020
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub